U.S. Patent No. 8,758,286 Issued To ExThera Medical, Whose Seraph® Technology Is Designed To Combat Drug-Resistant “Superbugs”

BERKELEY, Calif.--(BUSINESS WIRE)--ExThera Medical Corporation announced today that U.S. Patent No. 8,758,286 has been issued to the Company relating to its Seraph® Microbind® Affinity Blood Filter (Seraph). ExThera Medical also announced that it has listed an executive summary of its business at www.HealthiosXchange (H/X), an equity-based portal for accredited investors that raises funds under Rule 506 (b).

Help employers find you! Check out all the jobs and post your resume.